Perceptions on coordination of care in prostate cancer patients treated with radiotherapy (RT) and androgen deprivation therapy (ADT): Implications for survivorship care planning.

被引：0
|
作者：
Holmes, Jordan A.
Anderson, Roger F.
Hoffman, Leroy G.
Showalter, Timothy Norman
Kasibhatla, Mohit S.
Collins, Sean P.
Papagikos, Michael A.
Barbosa, Brittney Diane
Stravers, Lori
Mahbooba, Zahra
Wang, Andrew
Chen, Ronald C.
机构：
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, REX Radiat Oncol, Raleigh, NC USA
[3] Univ Virginia, Charlottesville, VA USA
[4] High Point Reg Med Ctr, High Point, NC USA
[5] Georgetown Univ, Med Ctr, Washington, DC 20007 USA
[6] Coastal Carolina Rad Onc, Wilmington, NC USA
[7] Dept Radiat Oncol, Chapel Hill, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.10102
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10102
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Long-term health care costs for prostate cancer patients on androgen deprivation therapy
    Krahn, M. D.
    Bremner, K. E.
    Luo, J.
    Tomlinson, G.
    Alibhai, S. M. H.
    CURRENT ONCOLOGY, 2016, 23 (05) : E443 - E453
  • [22] Improved survival of men with metastatic prostate cancer treated with androgen deprivation therapy plus radiotherapy to the prostate
    Yano, Akihiro
    Kagawa, Makoto
    Takeshita, Hideki
    Okada, Yohei
    Morozumi, Makoto
    Kawakami, Satoru
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (12) : 863 - 865
  • [23] Androgen deprivation therapy in advanced prostate cancer: is intermittent therapy the new standard of care?
    Klotz, L.
    Toren, P.
    CURRENT ONCOLOGY, 2012, 19 : S13 - S21
  • [24] Predictors of psychological distress (PD) in patients undergoing androgen deprivation therapy (ADT) for prostate cancer (PC)
    Asvat, Yasmin
    Jim, Heather
    Estrella, Tim
    Small, Brent
    Gielissen, Marieke
    Patterson, Stephen
    Jacobsen, Paul
    ANNALS OF BEHAVIORAL MEDICINE, 2008, 35 : S73 - S73
  • [25] Cataracts among elderly prostate cancer patients receiving androgen deprivation therapy (ADT) in the United States
    Beebe-Dimmer, J.
    Schwartz, K. A.
    Cetin, K.
    Morgenstern, H.
    Yee, C.
    Bartoces, M.
    Shahinian, V. B.
    Fryzek, J.
    Acguavella, J. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] REMOTELY-MONITORED SLEEP MEASURES IN PROSTATE CANCER PATIENTS UNDERGOING ANDROGEN DEPRIVATION THERAPY (ADT)
    Noorvash, Brandon
    Jarman, Aubrey
    Raines, Carolina
    Posadas, Edwin M.
    Sandler, Howard M.
    Freedland, Stephen J.
    Gresham, Gillian
    JOURNAL OF UROLOGY, 2023, 209 : E387 - E388
  • [27] INTENSITY-MODULATED RADIOTHERAPY REDUCES GASTROINTESTINAL TOXICITY IN PATIENTS TREATED WITH ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER
    Sharma, Navesh K.
    Li, Tianyu
    Chen, David Y.
    Pollack, Alan
    Horwitz, Eric M.
    Buyyounouski, Mark K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (02): : 437 - 444
  • [28] Enhancing Androgen Deprivation Therapy (ADT) integration in prostate cancer: Insights for Stereotactic Body Radiotherapy (SBRT) and brachytherapy modalities
    Gomez-Iturriaga, A.
    Buechser, D.
    Lopez-Campos, F.
    Maldonado, X.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 45
  • [29] Adjusting the duration of androgen deprivation therapy (ADT) based on nadir PSA for high risk localized prostate cancer patients treated with definitive external beam radiation therapy and ADT
    Zeina Ayoub
    Jamal Khader
    Muhammad Bulbul
    Raja B. Khauli
    Therese Y. Andraos
    Ali Shamseddine
    Deborah Mukherji
    Fady B. Geara
    BMC Urology, 22
  • [30] Adjusting the duration of androgen deprivation therapy (ADT) based on nadir PSA for high risk localized prostate cancer patients treated with definitive external beam radiation therapy and ADT
    Ayoub, Zeina
    Khader, Jamal
    Bulbul, Muhammad
    Khauli, Raja B. B.
    Andraos, Therese Y. Y.
    Shamseddine, Ali
    Mukherji, Deborah
    Geara, Fady B. B.
    BMC UROLOGY, 2022, 22 (01)
12345